Equities Research Analysts’ Downgrades for July 22nd (ACAD, ADVM, ALX, AROW, BMRN, BSIG, FITB, FUNC, GDDY, MTRN)

Equities Research Analysts’ downgrades for Monday, July 22nd:

ACADIA Pharmaceuticals (NASDAQ:ACAD) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Alexander’s (NYSE:ALX) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Arrow Financial (NASDAQ:AROW) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

BioMarin Pharmaceutical (NASDAQ:BMRN) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

BrightSphere Investment Group (NYSE:BSIG) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Fifth Third Bancorp (NASDAQ:FITB) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

First United (NASDAQ:FUNC) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

GoDaddy (NYSE:GDDY) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Materion (NYSE:MTRN) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

NovaGold Resources (NYSEAMERICAN:NG) (TSE:NG) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Security National Financial (NASDAQ:SNFCA) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Tompkins Financial (NYSEAMERICAN:TMP) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.